Hansa Biopharma AB, ("Hansa" or "the Company"), , today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for imlifidase. The Company is ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

Many developers spend years chasing ideas that don’t meaningfully improve their skills. From productivity myths to learning shortcuts, these beliefs quietly drain time and motivation. Some are ...

Apple, Michigan taxpayers, and one of Detroit’s wealthiest families spent roughly $30 million training hundreds of people to ...

There are tons of brilliant open-source apps. You'll find open-source titles for Linux, MacOS, and Windows. Some of these apps are so good, they should have a price tag. Since I started my journey ...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...

Discover the top 3 undervalued Automobile Components stocks for Friday, December 26 based on AAII’s Stock Grades.

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab has been approved in the US for the 1st-line treatment of adult patients with unresectable or ...

Many popular apps collect more of your personal data than necessary to function properly. These 20 apps quietly scoop up your photos, location, contacts, and more. Here's how to protect yourself. I ...

PADCEV plus Keytruda is the first and only regimen without platinum-based chemotherapy to improve event-free and overall survival when used before and after surgery ...

I’m not a big fan of the subscription economy. It seems like most apps are trying to get us to pay a monthly — or yearly — subscription these days, a stark contrast to the times when getting full ...